Related Experiment Videos
Comparative genomic hybridization analysis of clear cell sarcoma of the kidney
1Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Background:
Clear cell sarcoma of the kidney (CCSK) is a rare malignant pediatric tumor, distinguished from the Wilms tumor by its characteristic histologic features and a more aggressive clinical behavior with a tendency to metastasize to bone. Genetic studies on CCSK are limited and no consistent findings have been reported.
Procedure:
We examined four cases of CCSK for presence of consistent genetic alterations using comparative genomic hybridization (CGH). This is the first report concerning CGH analysis of CCSK.
Results:
Three of the tumors showed no chromosome gains or losses. One of the tumors had gains of 1 q and the terminal end of 11 q.
Conclusions:
These results are consistent with previous findings of limited chromosomal changes in CCSK karyotypes. Gain of 1 q in CCSK warrants further investigation. Copy number gains of 1 q have been repeatedly demonstrated in soft tissue and bone sarcomas, as well as other tumors, implying the presence of genes involved in tumor development and/or progression.
Insights
Clear cell sarcoma of the kidney (CCSK) is a rare pediatric cancer. Genetic analysis revealed limited chromosomal changes, with one tumor showing gains on chromosome 1q, suggesting potential genes involved in tumor development.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Genitourinary Pathology
Background:
- Clear cell sarcoma of the kidney (CCSK) is a rare pediatric malignancy.
- CCSK exhibits distinct histology and aggressive behavior compared to Wilms tumor.
- Limited genetic studies exist for CCSK, with no consistent findings reported.
Purpose of the Study:
- To investigate consistent genetic alterations in CCSK.
- To perform comparative genomic hybridization (CGH) analysis on CCSK cases.
- To establish a genetic basis for CCSK and its aggressive nature.
Main Methods:
- Comparative Genomic Hybridization (CGH) was performed on four CCSK tumor samples.
- CGH analysis aimed to detect chromosomal gains and losses.
- This study represents the first CGH analysis reported for CCSK.
Main Results:
- Three out of four CCSK tumors displayed no significant chromosomal gains or losses.
- One CCSK tumor exhibited gains on chromosome 1q and the terminal region of chromosome 11q.
- These findings indicate minimal chromosomal instability in most CCSK cases.
Conclusions:
- The observed limited chromosomal changes align with previous CCSK karyotype findings.
- Gain of chromosome 1q in CCSK requires further investigation.
- Recurrent 1q gains in various sarcomas suggest involvement of specific genes in tumor progression.